Curebound, a philanthropic organization dedicated to cancer research, has awarded eight grants totaling $2 million to innovative oncology-based projects.
These grants support pre-series A life science companies conducting groundbreaking research with commercialization potential. They provide up to $250,000 to projects that aim to develop transformative products, therapies, or services for cancer treatment. Awarded recipients include:
• Beken Bio: Liquid biopsy detection of ovarian cancer
• Pillar: Prevention and Diagnostic Tools
• Palm Therapeutics: Preclinical development of NRAS inhibitors for NRAS mutant cancers
• Pillar: Novel Approaches and New Therapeutic Platforms
• Resolute Science: Targeting macrophages to treat glioblastoma
• Pillar: Novel Approaches and New Therapeutic Platforms
• Seren Bio: Development of DMGV analogs for colorectal cancer therapy
• Pillar: Novel Approaches and New Therapeutic Platforms
Focused on reducing cancer-related health disparities, Equity Grants provide up to $250,000 to researchers investigating ways to improve access to quality care, cancer prevention, screening, and detection in underserved populations. Awarded recipients include:
• “Enhancing Lung Cancer Screening Engagement for Primary Care Patients in Low Income Communities”
• Investigators: David Strong, PhD (UC San Diego), Job Godino, PhD (Family Health Center of San Diego)
• Pillar: Cancer Equities, Prevention and Diagnostic Tool
• “Screening with Liquid Biopsies to Address Colorectal Cancer Inequities”
• Investigators: Samir Gupta, MD (UC San Diego), Job Godino, PhD (Family Health Center of San Diego)
• Pillar: Cancer Equities, Prevention
Curebound’s CEO, Anne Marbarger, emphasized the importance of these grants in accelerating cancer cures across populations. The rigorous review process ensures that projects with the potential to reach patients are prioritized.
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.
